Willow Biosciences Inc (WLLW) — Cash Flow Reinvestment Rate

Latest as of March 2019: 2.89x

Willow Biosciences Inc (WLLW) has a Cash Flow Reinvestment Rate of 2.89x as of March 2019, reinvesting CA$29.33K (capex CA$14.67K plus investments CA$-14.67K) from operating cash flow of CA$10.14K. See WLLW FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

2.89x

(Capex + Investments) / Operating CF

Total Reinvested

CA$29.33K

Capex + Investments

Operating Cash Flow

CA$10.14K

CAD

Capital Expenditures

CA$14.67K

CAD

Willow Biosciences Inc Cash Flow Reinvestment Rate (2001–2001)

Historical reinvestment intensity for Willow Biosciences Inc across 1 annual periods. For the full cash flow conversion analysis, see Willow Biosciences Inc (WLLW) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for Willow Biosciences Inc (2001–2001)

Year-by-year capital reinvestment analysis for Willow Biosciences Inc. See WLLW financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2001	0.00x	CA$0.00	CA$281.00	CA$0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow